Growth Metrics

Core Laboratories (CLB) Long-Term Deferred Tax (2022 - 2025)

Core Laboratories (CLB) has 4 years of Long-Term Deferred Tax data on record, last reported at $70.5 million in Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax rose 0.8% year-over-year to $70.5 million; the TTM value through Sep 2025 reached $70.5 million, up 0.8%, while the annual FY2024 figure was $69.6 million, 0.6% up from the prior year.
  • Long-Term Deferred Tax reached $70.5 million in Q3 2025 per CLB's latest filing, roughly flat from $70.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $72.3 million in Q3 2023 and bottomed at $66.3 million in Q1 2024.
  • Average Long-Term Deferred Tax over 4 years is $69.4 million, with a median of $69.6 million recorded in 2024.
  • The widest YoY moves for Long-Term Deferred Tax: up 2.56% in 2024, down 3.29% in 2024.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $68.6 million in 2022, then increased by 0.92% to $69.2 million in 2023, then rose by 0.6% to $69.6 million in 2024, then grew by 1.28% to $70.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $70.5 million in Q3 2025, $70.5 million in Q2 2025, and $67.5 million in Q1 2025.